Article in Frontiers in genome editing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors at 1 institution in 1 country.
Jenna Kropp SchmidtWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
Yun Hee KimWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
Nick StrelchenkoWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
Sarah R GierczicWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
Derek PavelecUniversity of Wisconsin Biotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Thaddeus G GolosWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
Igor I SlukvinWisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, United States.
University of Wisconsin–Madison · US
Funding
WNPRC Supplemental Request for Nonhuman Primate Enclosures to Equip HIV/AIDS-Related Research FacilitiesP51OD011106 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI Dorota A. Grejner-Brzezinska · 2012 to 2026
$150.7M
EXTRAMURAL RES FACIL CONST: REPRODUCTIVE, GROWTH &DVMT, MENOPAUSEC06RR020141 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2004 to 2004
$3.6M
CCR5-mutant monkey model to facilitate the development of novel stem cell-based therapies for AIDSR24OD021322 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI GOLOS, THADDEUS G, SLUKVIN, IGOR I. · 2016 to 2019
$3.3M
EXTRAMURAL REGIONAL FACILITIES CONSTRUCTIONC06RR015459 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI CADWALLADER, MARTIN · 2000 to 2000
$1.9M
Primate-specific miRNAs in Embryonic and Placental DevelopmentR00HD099154 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SCHMIDT, JENNA ANN · 2023 to 2025
$745k
Primate-specific miRNAs in Embryonic and Placental DevelopmentK99HD099154 · NICHD · UNIVERSITY OF WISCONSIN-MADISON · PI SCHMIDT, JENNA ANN · 2019 to 2021
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Whole genome sequencing of · full record | OpenQuestion